Page last updated: 2024-10-29

ketanserin and Glaucoma, Suspect

ketanserin has been researched along with Glaucoma, Suspect in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"A series of ketanserin analogs were studied for their effects on intraocular pressure (IOP) recovery curve of rabbits infused with hypertonic saline."3.68Ocular hypotensive actions of serotonin antagonist-ketanserin analogs. ( Chiou, GC; Li, BH, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiou, GC1
Li, BH1
Costagliola, C1
Fasano, ML1
Iuliano, G1
Ferrara, LA1

Trials

1 trial available for ketanserin and Glaucoma, Suspect

ArticleYear
Effects of ketanserin on intraocular pressure.
    Cardiovascular drugs and therapy, 1990, Volume: 4 Suppl 1

    Topics: Adult; Blood Pressure; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Ket

1990

Other Studies

1 other study available for ketanserin and Glaucoma, Suspect

ArticleYear
Ocular hypotensive actions of serotonin antagonist-ketanserin analogs.
    Journal of ocular pharmacology, 1992,Spring, Volume: 8, Issue:1

    Topics: Animals; Glaucoma; Intraocular Pressure; Ketanserin; Ocular Hypertension; Ocular Hypotension; Rabbit

1992